X
    學術可視化工作室RC   登錄   提交文稿
學術英文編修

CURRENT PHARMACEUTICAL BIOTECHNOLOGY

期刊標題檢索 CURR PHARM BIOT 最新評論: It took more than two months to start the external review, which is su... (2024-02-28)


期刊名稱:   ISSN:   主題領域:   影響因子範圍: -
索引:   類別:   開放訪問:   排序方式:

[CURRENT PHARMACEUTICAL BIOTECHNOLOGY]您好,您是該頁面的第 41323 位訪客。

期刊簡介
期刊名稱CURRENT PHARMACEUTICAL BIOTECHNOLOGY CURRENT PHARMACEUTICAL BIOTECHNOLOGY
LetPub Score
5.4
50 ratings
Rate

Reputation
6.4

Influence
4.1

Speed
7.0

期刊簡稱CURR PHARM BIOTECHNO
ISSN1389-2010
E-ISSN1873-4316
h-index73
CiteScore
CiteScoreSJRSNIPCiteScore Rank
5.600.4920.547
Subject fieldQuartilesRankPercentile
Category: Pharmacology, Toxicology and Pharmaceutics
Subcategory: Pharmaceutical Science
Q262 / 183
Category: Pharmacology, Toxicology and Pharmaceutics
Subcategory: Biotechnology
Q2128 / 311

自引率 (2023-2024)4.50%自引率趨勢
掲載範囲
Current Pharmaceutical Biotechnology aims to cover all the latest and outstanding developments in Pharmaceutical Biotechnology. Each issue of the journal includes timely in-depth reviews, original research articles and letters written by leaders in the field, covering a range of current topics in scientific areas of Pharmaceutical Biotechnology. Invited and unsolicited review articles are welcome. The journal encourages contributions describing research at the interface of drug discovery and pharmacological applications, involving in vitro investigations and pre-clinical or clinical studies. Scientific areas within the scope of the journal include pharmaceutical chemistry, biochemistry and genetics, molecular and cellular biology, and polymer and materials sciences as they relate to pharmaceutical science and biotechnology. In addition, the journal also considers comprehensive studies and research advances pertaining food chemistry with pharmaceutical implication. Areas of interest include:

DNA/protein engineering and processing
Synthetic biotechnology
Omics (genomics, proteomics, metabolomics and systems biology)
Therapeutic biotechnology (gene therapy, peptide inhibitors, enzymes)
Drug delivery and targeting
Nanobiotechnology
Molecular pharmaceutics and molecular pharmacology
Analytical biotechnology (biosensing, advanced technology for detection of bioanalytes)
Pharmacokinetics and pharmacodynamics
Applied Microbiology
Bioinformatics (computational biopharmaceutics and modeling)
Environmental biotechnology
Regenerative medicine (stem cells, tissue engineering and biomaterials)
Translational immunology (cell therapies, antibody engineering, xenotransplantation)
Industrial bioprocesses for drug production and development
Biosafety
Biotech ethics

Special Issues devoted to crucial topics, providing the latest comprehensive information on cutting-edge areas of research and technological advances, are welcome.

Current Pharmaceutical Biotechnology is an essential journal for academic, clinical, government and pharmaceutical scientists who wish to be kept informed and up-to-date with the latest and most important developments.
官方網站http://benthamscience.com/journal/index.php?journalID=cpb
在線稿件提交http://benthamscience.com/journal/authors-guidelines.php?journalID=cpb#top
開放訪問No
出版商Bentham Science Publishers B.V.
主題領域医学
出版國/地區UNITED STATES
發行頻率隔月刊行
創刊年2000
每年文章數139每年文章數趨勢
黃金OA百分比0.66%
Web of Science 四分位
2023-2024
WOS Quartile: Q3

CategoryEditionJIF QuartileJIF RankingJIF Percentage
BIOCHEMISTRY & MOLECULAR BIOLOGYSCIEQ4237/313
PHARMACOLOGY & PHARMACYSCIEQ3204/354
索引 (SCI or SCIE)Science Citation Index Expanded
鏈接到PubMed Central (PMC)https://www.ncbi.nlm.nih.gov/nlmcatalog?term=1389-2010%5BISSN%5D
平均審稿時間 *來自出版商的數據:
來自作者的數據: Ordinary, 3-6 Week(s)
競爭力 *來自作者的數據: Easy
參考鏈接
相關期刊 【CURRENT PHARMACEUTICAL BIOTECHNOLOGY】CiteScore趨勢
自引率趨勢 每年文章數趨勢
作者評論
*所有的審稿過程指標,如接受率和審稿速度,僅限於用戶提交的稿件。因此,這些指標可能無法準確反映期刊的競爭力或速度。
  • 同一學科的期刊
  • CiteScore趨勢
  • 自引率趨勢
  • 每年文章數趨勢
  •  
    學科內的可信期刊 影響因子
    NATURE MEDICINEH-index: 497

    CiteScore: 100.90
    CELLH-index: 705

    CiteScore: 110.00
    Molecular CancerH-index: 103

    CiteScore: 54.90
    Molecular PlantH-index: 85

    CiteScore: 37.60
    NUCLEIC ACIDS RESEARCHH-index: 452

    CiteScore: 27.10
    Molecular CellH-index: 356

    CiteScore: 26.00
    PROGRESS IN LIPID RESEARCHH-index: 132

    CiteScore: 24.50
    TRENDS IN MICROBIOLOGYH-index: 172

    CiteScore: 25.30
    CELL DEATH AND DIFFERENTIATIONH-index: 193

    CiteScore: 24.70
    Nature Chemical BiologyH-index: 182

    CiteScore: 23.90
    學科內最受檢索的期刊 頁面查看次數
    International Journal of Biological Macromolecules1283130
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS571262
    JOURNAL OF BIOLOGICAL CHEMISTRY396014
    NUCLEIC ACIDS RESEARCH338241
    CELL298305
    FASEB JOURNAL267377
    International Journal of Biological Sciences237026
    PLANT SCIENCE228223
    Molecular Cancer217326
    ONCOGENE201042
  •  

    CURRENT PHARMACEUTICAL BIOTECHNOLOGY CURRENT PHARMACEUTICAL BIOTECHNOLOGY
    明年預測:
    穩步上升 無變化 逐步下降  刷新
  •  

     
  •  

     


首頁    上一頁    1    下一頁    末頁  (頁
/1)
  [CURRENT PHARMACEUTICAL BIOTECHNOLOGY] 的評論撰寫評論
作者: zero 00


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-02-28 10:58:52 評論於
It took more than two months to start the external review, which is supposed to take 2-4 weeks according to the external review website. It has been over 3 weeks now and still no news
(0) 讚! | zero 00

作者: Andre Eliot


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-05-02 11:05:07 評論於
How did it go later? Did you pay for the fast pass?
(0) 讚! | Andre Eliot

作者: TonyCJLU


領域: 生物学
審稿時間: 2.0 month(s)
結果: 修改後接受


撰寫評論

2022-09-21 09:01:02 評論於
Four reviewers provided a lot of comments, and the students made efforts to revise and supplemented with two additional experiments.
The overall charges collected are not low, and if the fast publication fee is not paid, the formal publication will be particularly slow.
(2) 讚! | TonyCJLU

作者: 平原海雁


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2022-09-19 12:38:45 評論於
Review speed: 24.0 experience sharing: two months, no news after submission. Only received one email for paid expedited review, haha
(0) 讚! | 平原海雁

作者: gliangw


領域: 医学
審稿時間: 2.0 month(s)
結果: 修改後接受


撰寫評論

2021-10-19 08:55:37 評論於
Received: August 13, 2020
Revised: October 23, 2020
Accepted: October 23, 2020
The Impact Factor (IF) announced in 2021 has reached 2.837, showing a significant increase compared to the previous year. Students who have graduation requirements may consider submitting their work.
(1) 讚! | gliangw

作者: 匿名


領域:
審稿時間: 0.0 month(s)
結果:


撰寫評論

2013-11-23 14:47:00 評論於
Journal Homepage URL: http://www.benthamsciencepublisher.com/cpb/
(0) 讚! | 匿名

作者: 凌霄高洁


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2012-11-28 21:01:59 評論於
Can we make it to top 3 next year? Let's discuss
(0) 讚! | 凌霄高洁

首頁    上一頁    1    下一頁    末頁  (頁
/1)

開始撰寫 [CURRENT PHARMACEUTICAL BIOTECHNOLOGY] 的評論:





Contact us

Contact us  

Your name*

Your email*

Your message*

Please fill in all fields and provide a valid email.

Security Code*